Ibrutinib for treating relapsed or refractory mantle cell lymphoma

Equality Impact Assessment (Guidance development) (PDF 234 KB)

Final appraisal determination: 1

Committee papers (PDF 2.38 MB)

Final appraisal determination document (PDF 523 KB)

Public committee slides (PDF 1.24 MB)

Draft guidance: 2

Appraisal consultation document 2 (PDF 423 KB)

Committee papers (PDF 944 KB)

Draft guidance

Committee papers (PDF 11.64 MB)

Appraisal consultation document (PDF 290 KB)

Committee papers presentation slides (PDF 328 KB)

Committee papers presentation slides (PDF 417 KB)

Final scope (PDF 142 KB)

Final matrix (PDF 101 KB)

NICE's response to comments on the draft scope and provisional matrix (PDF 187 KB)

Equality Impact Assessment (Guidance development) (PDF 118 KB)

Draft scope (post-referral) (PDF 146 KB)

Provisional matrix (post-referral) (PDF 99 KB)

Draft scope for consultation (pre-referral) July 2014 (PDF 111 KB)

Provisional matrix (pre-referral) July 2014 (PDF 105 KB)